Deucravacitinib: a novel TYK2 inhibitor for the treatment of moderate-to-severe psoriasis

Burshtein J, Bunick CG, Vleugels RA, Armstrong AW, Golant AK, Schlesinger T, Strober BE, Song EJ, Gold LS, Lebwohl M. Systemic Corticosteroid Use in Atopic[...]

Morales A, Korsakova E, Mansooralavi N, Soliman P, Jahanbani S, Olsen ML, Badhuri A, Lowry WE. Evidence of neuronal DNA damage in the brains of[...]

Fu G, Rushing BR, Graves L, Nieman DC, Pellegrini M, Soldano M, Thompson MJ, Sakaguchi CA, Pathmasiri W, Sumner SJ. Multi-omics signature of healthy versus[...]